Next Article in Journal
Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265
Next Article in Special Issue
SOCS1 Deficiency Promotes Hepatocellular Carcinoma via SOCS3-Dependent CDKN1A Induction and NRF2 Activation
Previous Article in Journal
Minimally Invasive Anatomical Segmentectomy versus Lobectomy in Stage IA Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Previous Article in Special Issue
Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma
 
 
Article

Article Versions Notes

Cancers 2022, 14(24), 6162; https://doi.org/10.3390/cancers14246162
Action Date Notes Link
article xml file uploaded 14 December 2022 09:50 CET Original file -
article xml uploaded. 14 December 2022 09:50 CET Update -
article pdf uploaded. 14 December 2022 09:50 CET Version of Record https://www.mdpi.com/2072-6694/14/24/6162/pdf-vor
article supplementary file uploaded. 14 December 2022 09:50 CET - https://www.mdpi.com/2072-6694/14/24/6162#supplementary
article html file updated 14 December 2022 09:52 CET Original file -
article supplementary file uploaded. 15 December 2022 09:33 CET - https://www.mdpi.com/2072-6694/14/24/6162#supplementary
article html file updated 15 December 2022 09:34 CET Update -
article xml file uploaded 21 December 2022 10:54 CET Update -
article xml uploaded. 21 December 2022 10:54 CET Update https://www.mdpi.com/2072-6694/14/24/6162/xml
article pdf uploaded. 21 December 2022 10:54 CET Updated version of record https://www.mdpi.com/2072-6694/14/24/6162/pdf
article html file updated 21 December 2022 10:56 CET Update -
article html file updated 1 March 2023 04:08 CET Update -
article html file updated 4 March 2023 21:32 CET Update https://www.mdpi.com/2072-6694/14/24/6162/html
Back to TopTop